Related Experiment Video

Updated: Mar 20, 2026

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
07:29

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Published on: April 22, 2019

12.4K

Nivolumab for Metastatic Melanoma

A K Gupta1, D Daigle2

  • 1Department of Medicine, University of Toronto School of Medicine, Toronto, ON, Canada; Mediprobe Research Inc., London, ON, Canada.

Skin Therapy Letter
|May 26, 2016
PubMed

Insights

Nivolumab, a novel biologic agent, improves outcomes for advanced melanoma patients by blocking immune checkpoints. This immunotherapy offers superior efficacy and safety compared to traditional chemotherapy for metastatic skin cancer.

Area of Science:

  • Oncology
  • Immunology
  • Dermatology

Background:

  • Melanoma, particularly at Stage III-IV, presents a poor prognosis with traditional treatments.
  • Malignant cells exploit immune checkpoints to evade immune detection.
  • Current treatments include surgical resection and systemic chemotherapy.

Purpose of the Study:

  • To evaluate the efficacy and safety of Nivolumab in treating advanced melanoma.
  • To explore the mechanism of Nivolumab in enhancing anti-tumor immune response.

Main Methods:

  • Nivolumab is a human monoclonal antibody targeting the PD-1 immune checkpoint.
  • Clinical trials assessed Nivolumab's performance against standard chemotherapy.

Main Results:

  • Nivolumab demonstrated superior efficacy compared to standard chemotherapy.
  • Nivolumab showed a favorable safety profile in clinical trials.
  • The drug enhances tumor-specific T cell proliferation by preventing immune inhibition.

Conclusions:

  • Nivolumab represents a significant advancement in treating advanced melanoma.
  • Novel biologic agents like Nivolumab are improving patient outcomes in metastatic melanoma.
  • Targeting immune checkpoints offers a promising therapeutic strategy for aggressive skin cancers.

More Related Videos

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

3.0K
Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

4.2K

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

1.5K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.7K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.3K